Solara Active Pharma Q2 FY27: Net profit hits Rs28.46 Cr as EBITDA margin expands to 18.5% and revenue climbs to Rs417.34 Cr
India, Oct. 16 -- It is an Indian pharmaceutical firm that concentrates on the development and production of Active Pharmaceutical Ingredients (API). The active pharmaceutical ingredients are the essential components that provide the medicinal efficacy in drugs. The firm provides pharmaceutical ingredients to its customers in both local and international markets..
The shares of Solara Active Pharma are currently trading at Rs. 691.70, up by 6.96%. The company has a market capitalization of Rs. 3,325.02 crore. The stock's 52 week high is Rs. 774.00 and its 52 week low is Rs. 422.00. In the past 6 months the stock has delivered a return of 40.79%.
What's the News
Solara Active Pharma Sciences reported a consolidated net profit of Rs. 28...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.